November 17, 2021 Bayer, Microsoft Enter into Strategic Partnership to Optimize and Advance Digital Capabilities for Food, Feed, Fuel, Fiber Value ChainRead more
SPECIALIZED PRESS November 15, 2021 Not intended for U.S. and UK MediaBayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney diseaseRead more
November 15, 2021 Director-General of United Nation’s Food and Agriculture Organization to share his vision at Bayer’s Youth Ag SummitRead more
SPECIALIZED PRESS November 11, 2021 Not intended for U.S. and UK MediaNew Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fractionRead more
SPECIALIZED PRESS November 10, 2021 Not intended for U.S. and UK MediaBayer Submits Aflibercept for regulatory approval in the EU and Japan for Retinopathy of Prematurity in premature babiesRead more
November 9, 2021 Effective January 1, 2022:Rodrigo Santos named member of the Board of Management, Bayer AG, and President of the Crop Science divisionRead more
SPECIALIZED PRESS November 8, 2021 Not intended for U.S. and UK Media - The American Society of Nephrology (ASN)’s Kidney Week 2021:New data from finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D independent of baseline therapyRead more
SPECIALIZED PRESS November 5, 2021 Not intended for U.S. and UK Media - The American Heart Association Scientific Sessions 2021:Bayer to present data from cardiovascular portfolio, including analyses from the comprehensive finerenone clinical trial program, VOYAGER PAD (Xarelto™) and the VICTORIA trial (Verquvo™)Read more
